Christine M Thorburn, MD
Rheumatology · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Thorburn’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A73049 · Current
Licensed to practise in California · since 2000 · expires 2028-09-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$54,735
Medicare paid this office $54,735 for 264 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 217 | $38,850 | $112 |
| New patient visit (45+ min) | 21 | $3,175 | $151 |
| New patient visit (30+ min) | 22 | $2,210 | $100 |
| Long return visit (40+ min) | 13 | $2,161 | $166 |
| Short return visit (20+ min) | 15 | $1,556 | $86 |
See all 7 services
| Return visit (30+ min) | 217 | $38,850 | $112 |
| New patient visit (45+ min) | 21 | $3,175 | $151 |
| New patient visit (30+ min) | 22 | $2,210 | $100 |
| Long return visit (40+ min) | 13 | $2,161 | $166 |
| Short return visit (20+ min) | 15 | $1,556 | $86 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 42 | $657 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $70 | None |
Who their Medicare patients are
264 Original Medicare patients in 2024. Average age 75 · Women 74% · Health risk score 1.23. At or below the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 59% · Coronary heart disease 23% · Chronic kidney disease 18% · Diabetes 17% · Atrial fibrillation 14% · Cancer 13% · COPD 13% · Depression 13% · Heart failure 12%.
The office billed $191,077, Medicare allowed $73,304 and paid $54,735; for 671 services of 22 kinds; $3,689 of it was for drugs given in the office and $51,046 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 264 | 671 | 75 | 1.23 | $191,077 | $54,735 |
| 2023 | 211 | 533 | 74 | 1.17 | $133,880 | $40,003 |
| 2022 | 213 | 442 | 74 | 1.02 | $123,161 | $37,380 |
| 2021 | 271 | 602 | 75 | 1.00 | $157,662 | $49,909 |
| 2020 | 136 | 293 | 75 | 1.12 | $61,561 | $17,166 |
| 2019 | 352 | 956 | 74 | 1.15 | $210,929 | $57,888 |
| 2018 | 380 | 1,130 | 74 | 1.17 | $224,285 | $62,865 |
| 2017 | 392 | 1,133 | 74 | 1.17 | $228,590 | $65,672 |
| 2016 | 359 | 1,157 | 74 | 1.13 | $221,923 | $63,767 |
| 2015 | 390 | 1,280 | 74 | 1.18 | $258,284 | $78,829 |
| 2014 | 389 | 1,569 | 74 | 1.04 | $300,135 | $88,591 |
| 2013 | 344 | 1,212 | 74 | 1.02 | $228,924 | $64,883 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 164 | $28,498 | $110 |
| Short return visit (20+ min) | 34 | $3,512 | $76 |
| New patient visit (30+ min) | 11 | $1,192 | $108 |
| Aspiration and/or injection of fluid from large joint | 13 | $1,170 | $65 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 24 | $106 | None |
2022: 7 services
| Return visit (30+ min) | 158 | $26,595 | $113 |
| Long return visit (40+ min) | 15 | $2,883 | $152 |
| Short return visit (20+ min) | 28 | $2,693 | $77 |
| New patient visit (30+ min) | 18 | $1,390 | $77 |
| New patient visit (45+ min) | 12 | $1,067 | $89 |
| Aspiration and/or injection of fluid from large joint | 14 | $902 | $60 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 23 | $66 | None |
2021: 10 services
| Return visit (30+ min) | 166 | $28,526 | $115 |
| New patient visit (45+ min) | 40 | $5,930 | $148 |
| Short return visit (20+ min) | 42 | $3,761 | $74 |
| New patient visit (30+ min) | 27 | $2,807 | $104 |
| Long return visit (40+ min) | 16 | $2,496 | $156 |
| Aspiration and/or injection of fluid from large joint | 17 | $1,521 | $69 |
| Influenza vaccine split virus, preservative free | 16 | $1,044 | $65 |
| Injection into tendon at attachment to bone or muscle | 13 | $1,025 | $45 |
| Administration of influenza virus vaccine | 17 | $369 | $22 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 30 | $105 | None |
2020: 6 services
| Return visit (30+ min) | 89 | $10,217 | $87 |
| Short return visit (20+ min) | 42 | $2,708 | $63 |
| Aspiration and/or injection of fluid from large joint | 12 | $784 | $65 |
| Influenza vaccine split virus, preservative free | 12 | $720 | $60 |
| Administration of influenza virus vaccine | 15 | $312 | $21 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $63 | None |
2019: 10 services
| Return visit (30+ min) | 208 | $30,599 | $89 |
| New patient visit (45+ min) | 49 | $6,877 | $140 |
| Short return visit (20+ min) | 76 | $5,855 | $65 |
| Long return visit (40+ min) | 25 | $3,664 | $131 |
| New patient visit (30+ min) | 37 | $3,447 | $93 |
| Aspiration and/or injection of fluid from large joint | 38 | $2,748 | $55 |
| Influenza vaccine split virus, preservative free | 24 | $1,276 | $53 |
| Injection into tendon at attachment to bone or muscle | 16 | $744 | $39 |
| Administration of influenza virus vaccine | 26 | $531 | $20 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 56 | $282 | None |
2018: 12 services
| Return visit (30+ min) | 205 | $30,557 | $89 |
| Short return visit (20+ min) | 101 | $8,018 | $62 |
| New patient visit (45+ min) | 49 | $6,950 | $142 |
| Aspiration and/or injection of fluid from large joint | 48 | $3,972 | $58 |
| New patient visit (30+ min) | 40 | $3,581 | $90 |
| Long return visit (40+ min) | 23 | $2,987 | $130 |
| Injection into tendon at attachment to bone or muscle | 18 | $1,073 | $51 |
| Influenza vaccine split virus, preservative free | 18 | $794 | $44 |
| Administration of influenza virus vaccine | 25 | $640 | $26 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 69 | $451 | None |
| Short return visit | 14 | $426 | $30 |
| Aspiration and/or injection of fluid from small joint | 11 | $318 | $29 |
2017: 11 services
| Return visit (30+ min) | 224 | $31,728 | $88 |
| Short return visit (20+ min) | 106 | $8,553 | $62 |
| New patient visit (45+ min) | 56 | $7,547 | $135 |
| New patient visit (30+ min) | 44 | $4,137 | $94 |
| Aspiration and/or injection of fluid from large joint | 46 | $3,725 | $58 |
| Long return visit (40+ min) | 19 | $2,363 | $124 |
| Injection into tendon at attachment to bone or muscle | 18 | $1,040 | $43 |
| Influenza vaccine split virus, preservative free | 23 | $1,001 | $44 |
| Administration of influenza virus vaccine | 26 | $835 | $32 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 60 | $388 | None |
| Injection, methylprednisolone acetate, 80 mg | 13 | $174 | None |
2016: 10 services
| Return visit (30+ min) | 205 | $31,170 | $87 |
| Short return visit (20+ min) | 101 | $9,283 | $64 |
| New patient visit (45+ min) | 39 | $5,274 | $135 |
| New patient visit (30+ min) | 48 | $3,882 | $81 |
| Aspiration and/or injection of fluid from large joint | 50 | $3,826 | $55 |
| Long return visit (40+ min) | 18 | $2,570 | $128 |
| Influenza vaccine split virus, preservative free | 31 | $1,140 | $37 |
| Administration of influenza virus vaccine | 32 | $972 | $30 |
| Injection into tendon at attachment to bone or muscle | 13 | $745 | $53 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 61 | $403 | None |
2015: 15 services
| Return visit (30+ min) | 202 | $33,805 | $96 |
| Short return visit (20+ min) | 104 | $9,526 | $68 |
| New patient visit (45+ min) | 52 | $8,178 | $157 |
| New patient visit (30+ min) | 65 | $6,397 | $98 |
| Aspiration and/or injection of fluid from large joint | 60 | $5,156 | $61 |
| Long return visit (40+ min) | 27 | $3,752 | $134 |
| Pneumococcal vaccine, 13-valent | 17 | $2,549 | $150 |
| Injection into tendon at attachment to bone or muscle | 22 | $1,551 | $57 |
| Short return visit | 13 | $794 | $38 |
| Administration of influenza virus vaccine | 23 | $732 | $32 |
| Administration of pneumococcal vaccine | 22 | $668 | $30 |
| Influenza vaccine split virus, preservative free | 13 | $463 | $36 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 56 | $407 | None |
| Injection, methylprednisolone acetate, 80 mg | 21 | $135 | None |
| Injection, triamcinolone hexacetonide, per 5 mg | 15 | $28 | None |
2014: 18 services
| Return visit (30+ min) | 228 | $42,192 | $92 |
| Short return visit (20+ min) | 84 | $7,364 | $63 |
| Aspiration and/or injection of fluid from large joint | 78 | $7,327 | $56 |
| New patient visit (45+ min) | 51 | $6,915 | $136 |
| Long return visit (40+ min) | 32 | $4,530 | $129 |
| Pneumococcal vaccine, 13-valent | 27 | $3,987 | $148 |
| New patient visit (30+ min) | 41 | $3,786 | $92 |
| New patient visit (15+ min) | 22 | $1,370 | $62 |
| Injection into tendon at attachment to bone or muscle | 16 | $981 | $49 |
| Short return visit | 18 | $914 | $40 |
| Administration of pneumococcal vaccine | 27 | $820 | $30 |
| Administration of influenza virus vaccine | 22 | $699 | $30 |
| Aspiration and/or injection of fluid from small joint | 14 | $613 | $36 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 54 | $528 | None |
| Influenza vaccine split virus, preservative free | 11 | $360 | $33 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 11 | $212 | $18 |
| Injection, methylprednisolone acetate, 80 mg | 28 | $158 | None |
| Injection, triamcinolone hexacetonide, per 5 mg | 27 | $57 | None |
2013: 13 services
| Return visit (30+ min) | 167 | $29,726 | $92 |
| New patient visit (45+ min) | 53 | $7,651 | $144 |
| Short return visit (20+ min) | 101 | $7,156 | $58 |
| Aspiration and/or injection of fluid from large joint | 71 | $5,318 | $49 |
| New patient visit (30+ min) | 51 | $4,512 | $88 |
| Long return visit (40+ min) | 18 | $2,780 | $126 |
| New patient visit (15+ min) | 25 | $1,638 | $66 |
| Short return visit | 18 | $809 | $39 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 54 | $402 | None |
| Administration of influenza virus vaccine | 12 | $366 | $30 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $264 | $18 |
| Injection, methylprednisolone acetate, 80 mg | 24 | $111 | None |
| Injection, triamcinolone hexacetonide, per 5 mg | 16 | $48 | None |
Drugs they prescribed that Part D paid
$2,061,276
Pharmacies billed $2,061,276 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (97 of 1,486) in 2024. Above the middle of the specialty; the typical rheumatology clinician is at 3%.
1,173 generic and fewer than 11 brand-name prescriptions · $2,061,276 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Humira(Cf) | 39 | $452,240 | $11,596 |
| Enbrel Sureclick | 50 | $407,808 | $8,156 |
| Humira(Cf) | 38 | $274,765 | $7,231 |
| Xeljanz Xr | 44 | $267,814 | $6,087 |
| Otezla | 29 | $211,357 | $7,288 |
See all 29 drugs
| Humira(Cf) | 39 | $452,240 | $11,596 |
| Enbrel Sureclick | 50 | $407,808 | $8,156 |
| Humira(Cf) | 38 | $274,765 | $7,231 |
| Xeljanz Xr | 44 | $267,814 | $6,087 |
| Otezla | 29 | $211,357 | $7,288 |
| Rinvoq | 11 | $68,454 | $6,223 |
| Cimzia (2 Pack) | 12 | $64,606 | $5,384 |
| Actemra Actpen | 18 | $43,956 | $2,442 |
| Methotrexate | 211 | $6,363 | $30 |
| Hydroxychloroquine Sulfate | 132 | $6,112 | $46 |
| Prednisone | 232 | $2,861 | $12 |
| Hydrocodone-Acetaminophen | 66 | $2,104 | $32 |
| Risedronate | 16 | $1,518 | $95 |
| Febuxostat | 11 | $1,486 | $135 |
| Leucovorin | 30 | $1,400 | $47 |
| Allopurinol | 85 | $1,035 | $12 |
| Leflunomide | 16 | $1,029 | $64 |
| Sildenafil Citrate | 13 | $773 | $59 |
| Celecoxib | 20 | $754 | $38 |
| Sulfasalazine | 18 | $630 | $35 |
| Methylprednisolone | 25 | $506 | $20 |
| Folic Acid | 37 | $423 | $11 |
| Diclofenac | 27 | $408 | $15 |
| Zolpidem | 13 | $248 | $19 |
| Gabapentin | 18 | $244 | $14 |
| Meloxicam | 52 | $190 | $4 |
| Tramadol | 19 | $159 | $8 |
| Alendronate | 17 | $104 | $6 |
| Oxycodone-Acetaminophen | 12 | $82 | $7 |
Year by year
| 2024 | 1,486 | 239 | 7% (97) | None | $2,061,276 |
| 2023 | 1,488 | 227 | 7% (105) | None | $1,900,239 |
| 2022 | 1,768 | 274 | 8% (135) | None | $1,943,559 |
| 2021 | 1,697 | 254 | 7% (115) | None | $1,932,710 |
| 2020 | 1,573 | 240 | 5% (85) | None | $1,669,071 |
| 2019 | 1,895 | 339 | 10% (182) | None | $1,537,840 |
| 2018 | 1,921 | 308 | 9% (177) | None | $1,495,056 |
| 2017 | 1,974 | 291 | 9% (186) | None | $1,208,859 |
| 2016 | 1,938 | 268 | 9% (179) | None | $908,187 |
| 2015 | 1,930 | 269 | 9% (170) | 26% | $771,070 |
| 2014 | 1,823 | 261 | 11% (191) | None | $438,657 |
| 2013 | 1,397 | 201 | 11% (152) | None | $268,897 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 28 drugs
| Enbrel Sureclick | 45 | $349,820 | $7,774 |
| Humira(Cf) | 32 | $343,557 | $10,736 |
| Humira(Cf) | 30 | $267,819 | $8,927 |
| Xeljanz Xr | 36 | $245,881 | $6,830 |
| Otezla | 25 | $174,341 | $6,974 |
| Enbrel | 19 | $137,069 | $7,214 |
| Cosentyx Sensoready (2 Pens) | 11 | $83,059 | $7,551 |
| Actemra Actpen | 24 | $63,194 | $2,633 |
| Hydroxychloroquine Sulfate | 133 | $10,469 | $79 |
| Methotrexate | 214 | $10,441 | $49 |
| Febuxostat | 18 | $4,221 | $235 |
| Prednisone | 240 | $2,997 | $12 |
| Colchicine | 16 | $2,637 | $165 |
| Leucovorin | 41 | $2,505 | $61 |
| Sildenafil Citrate | 13 | $2,436 | $187 |
| Leflunomide | 23 | $2,363 | $103 |
| Celecoxib | 24 | $2,222 | $93 |
| Hydrocodone-Acetaminophen | 70 | $1,922 | $27 |
| Allopurinol | 104 | $1,809 | $17 |
| Diclofenac | 25 | $873 | $35 |
| Gabapentin | 27 | $564 | $21 |
| Alendronate | 35 | $300 | $9 |
| Meloxicam | 39 | $280 | $7 |
| Methylprednisolone | 11 | $247 | $22 |
| Zolpidem | 14 | $171 | $12 |
| Folic Acid | 28 | $110 | $4 |
| Oxycodone-Acetaminophen | 13 | $65 | $5 |
| Tramadol | 21 | $56 | $3 |
2022: 29 drugs
| Humira(Cf) | 39 | $379,797 | $9,738 |
| Xeljanz Xr | 53 | $323,810 | $6,110 |
| Enbrel Sureclick | 35 | $245,338 | $7,010 |
| Humira(Cf) | 31 | $235,648 | $7,602 |
| Enbrel | 27 | $180,575 | $6,688 |
| Orencia Clickject | 25 | $138,548 | $5,542 |
| Otezla | 20 | $135,399 | $6,770 |
| Methotrexate | 264 | $14,202 | $54 |
| Hydroxychloroquine Sulfate | 158 | $12,713 | $80 |
| Prednisone | 305 | $5,564 | $18 |
| Febuxostat | 21 | $5,419 | $258 |
| Leflunomide | 31 | $3,939 | $127 |
| Colchicine | 18 | $3,612 | $201 |
| Fentanyl | 16 | $2,493 | $156 |
| Leucovorin | 51 | $2,448 | $48 |
| Allopurinol | 140 | $2,404 | $17 |
| Hydrocodone-Acetaminophen | 76 | $2,100 | $28 |
| Sulfasalazine | 13 | $712 | $55 |
| Celecoxib | 18 | $652 | $36 |
| Diclofenac | 19 | $520 | $27 |
| Gabapentin | 34 | $471 | $14 |
| Methylprednisolone | 18 | $456 | $25 |
| Sulfasalazine Dr | 12 | $432 | $36 |
| Tramadol | 21 | $349 | $17 |
| Oxycodone-Acetaminophen | 19 | $304 | $16 |
| Meloxicam | 40 | $275 | $7 |
| Alendronate | 37 | $227 | $6 |
| Folic Acid | 20 | $127 | $6 |
| Zolpidem | 12 | $88 | $7 |
2021: 31 drugs
| Humira(Cf) | 41 | $354,384 | $8,644 |
| Humira(Cf) | 46 | $352,277 | $7,658 |
| Enbrel Sureclick | 36 | $225,866 | $6,274 |
| Xeljanz Xr | 37 | $218,610 | $5,908 |
| Otezla | 18 | $151,863 | $8,437 |
| Enbrel | 23 | $144,310 | $6,274 |
| Orencia Clickject | 17 | $89,003 | $5,235 |
| Cosentyx Pen (2 Pens) | 13 | $84,060 | $6,466 |
| Actemra | 17 | $36,647 | $2,156 |
| Hydroxychloroquine Sulfate | 160 | $16,465 | $103 |
| Methotrexate | 228 | $13,763 | $60 |
| Febuxostat | 25 | $7,787 | $311 |
| Leflunomide | 35 | $7,157 | $204 |
| Colchicine | 29 | $4,685 | $162 |
| Prednisone | 316 | $4,514 | $14 |
| Fentanyl | 21 | $3,159 | $150 |
| Allopurinol | 145 | $2,570 | $18 |
| Hydrocodone-Acetaminophen | 69 | $2,502 | $36 |
| Celecoxib | 21 | $1,758 | $84 |
| Leucovorin | 39 | $1,674 | $43 |
| Sulfasalazine | 16 | $1,124 | $70 |
| Diclofenac | 11 | $1,002 | $91 |
| Gabapentin | 21 | $714 | $34 |
| Azathioprine | 11 | $662 | $60 |
| Oxycodone-Acetaminophen | 11 | $529 | $48 |
| Omeprazole | 23 | $528 | $23 |
| Meloxicam | 43 | $278 | $6 |
| Alendronate | 22 | $234 | $11 |
| Zolpidem | 13 | $107 | $8 |
| Folic Acid | 12 | $89 | $7 |
| Tramadol | 12 | $41 | $3 |
2020: 26 drugs
| Humira(Cf) | 39 | $420,848 | $10,791 |
| Xeljanz Xr | 49 | $327,808 | $6,690 |
| Enbrel | 29 | $214,626 | $7,401 |
| Enbrel Sureclick | 21 | $177,583 | $8,456 |
| Humira(Cf) | 19 | $164,709 | $8,669 |
| Humira | 17 | $126,211 | $7,424 |
| Actemra | 25 | $55,300 | $2,212 |
| Hydroxychloroquine Sulfate | 147 | $19,903 | $135 |
| Febuxostat | 60 | $15,896 | $265 |
| Methotrexate | 217 | $14,632 | $67 |
| Leflunomide | 41 | $8,092 | $197 |
| Rasuvo | 11 | $5,483 | $498 |
| Prednisone | 274 | $4,263 | $16 |
| Colchicine | 14 | $3,213 | $229 |
| Allopurinol | 123 | $2,492 | $20 |
| Diclofenac | 31 | $2,471 | $80 |
| Celecoxib | 17 | $1,706 | $100 |
| Leucovorin | 30 | $1,569 | $52 |
| Hydrocodone-Acetaminophen | 45 | $1,514 | $34 |
| Mycophenolate Mofetil | 13 | $1,396 | $107 |
| Gabapentin | 31 | $774 | $25 |
| Duloxetine | 11 | $618 | $56 |
| Omeprazole | 15 | $414 | $28 |
| Methylprednisolone | 12 | $337 | $28 |
| Tramadol | 20 | $170 | $9 |
| Meloxicam | 38 | $115 | $3 |
2019: 34 drugs
| Enbrel | 25 | $227,419 | $9,097 |
| Xeljanz Xr | 39 | $225,991 | $5,795 |
| Humira | 35 | $220,354 | $6,296 |
| Humira | 25 | $186,368 | $7,455 |
| Humira(Cf) | 15 | $156,328 | $10,422 |
| Enbrel Sureclick | 17 | $131,628 | $7,743 |
| Humira(Cf) | 12 | $130,339 | $10,862 |
| Actemra | 14 | $33,683 | $2,406 |
| Uloric | 32 | $24,771 | $774 |
| Hydroxychloroquine Sulfate | 129 | $19,836 | $154 |
| Methotrexate | 211 | $14,278 | $68 |
| Leflunomide | 56 | $12,831 | $229 |
| Febuxostat | 23 | $8,725 | $379 |
| Colchicine | 30 | $8,460 | $282 |
| Prednisone | 362 | $5,431 | $15 |
| Diclofenac | 57 | $3,829 | $67 |
| Allopurinol | 158 | $3,278 | $21 |
| Hydrocodone-Acetaminophen | 81 | $2,852 | $35 |
| Mycophenolate Mofetil | 12 | $2,311 | $193 |
| Gabapentin | 54 | $2,298 | $43 |
| Fentanyl | 24 | $2,228 | $93 |
| Celecoxib | 26 | $1,916 | $74 |
| Sulfasalazine | 25 | $1,726 | $69 |
| Oxycodone-Acetaminophen | 29 | $1,285 | $44 |
| Leucovorin | 22 | $1,167 | $53 |
| Azathioprine | 14 | $921 | $66 |
| Nabumetone | 15 | $658 | $44 |
| Tramadol | 45 | $547 | $12 |
| Omeprazole | 15 | $534 | $36 |
| Zolpidem Tartrate Er | 12 | $468 | $39 |
| Methylprednisolone | 11 | $265 | $24 |
| Methotrexate | 12 | $215 | $18 |
| Meloxicam | 32 | $92 | $3 |
| Zolpidem | 16 | $87 | $5 |
2018: 30 drugs
| Humira | 42 | $333,990 | $7,952 |
| Enbrel Sureclick | 33 | $308,828 | $9,358 |
| Humira | 34 | $277,424 | $8,160 |
| Enbrel | 44 | $253,783 | $5,768 |
| Xeljanz Xr | 24 | $116,725 | $4,864 |
| Uloric | 74 | $51,934 | $702 |
| Hydroxychloroquine Sulfate | 128 | $25,272 | $197 |
| Actemra | 13 | $24,863 | $1,913 |
| Methotrexate | 254 | $17,965 | $71 |
| Leflunomide | 63 | $14,628 | $232 |
| Colchicine | 26 | $8,014 | $308 |
| Prednisone | 385 | $5,341 | $14 |
| Celecoxib | 30 | $3,860 | $129 |
| Allopurinol | 153 | $3,694 | $24 |
| Mycophenolate Mofetil | 15 | $2,903 | $194 |
| Hydrocodone-Acetaminophen | 86 | $2,615 | $30 |
| Gabapentin | 60 | $2,354 | $39 |
| Diclofenac | 34 | $1,972 | $58 |
| Oxycodone-Acetaminophen | 27 | $1,797 | $67 |
| Zolpidem Tartrate Er | 12 | $1,361 | $113 |
| Leucovorin | 26 | $1,268 | $49 |
| Fentanyl | 12 | $1,257 | $105 |
| Voltaren | 12 | $1,197 | $100 |
| Sulfasalazine | 13 | $1,031 | $79 |
| Tramadol | 48 | $731 | $15 |
| Omeprazole | 22 | $561 | $25 |
| Nabumetone | 19 | $490 | $26 |
| Methylprednisolone | 26 | $449 | $17 |
| Zolpidem | 14 | $135 | $10 |
| Meloxicam | 17 | $95 | $6 |
2017: 31 drugs
| Enbrel Sureclick | 44 | $345,579 | $7,854 |
| Humira | 50 | $328,922 | $6,578 |
| Enbrel | 45 | $244,852 | $5,441 |
| Xeljanz Xr | 12 | $46,412 | $3,868 |
| Uloric | 84 | $42,588 | $507 |
| Hydroxychloroquine Sulfate | 139 | $29,128 | $210 |
| Methotrexate | 288 | $21,184 | $74 |
| Leflunomide | 54 | $15,379 | $285 |
| Prednisone | 425 | $6,141 | $14 |
| Cevimeline | 14 | $5,136 | $367 |
| Colchicine | 19 | $4,106 | $216 |
| Colcrys | 12 | $3,310 | $276 |
| Allopurinol | 142 | $3,239 | $23 |
| Hydrocodone-Acetaminophen | 104 | $2,324 | $22 |
| Voltaren | 18 | $2,171 | $121 |
| Leucovorin | 34 | $1,632 | $48 |
| Celecoxib | 20 | $1,384 | $69 |
| Gabapentin | 60 | $1,070 | $18 |
| Sulfasalazine | 18 | $990 | $55 |
| Nabumetone | 27 | $876 | $32 |
| Diclofenac | 12 | $797 | $66 |
| Zolpidem Tartrate Er | 12 | $663 | $55 |
| Oxycodone-Acetaminophen | 27 | $492 | $18 |
| Tramadol | 46 | $484 | $11 |
| Omeprazole | 22 | $416 | $19 |
| Methylprednisolone | 21 | $343 | $16 |
| Cyclobenzaprine | 30 | $300 | $10 |
| Amitriptyline | 22 | $288 | $13 |
| Alendronate | 16 | $141 | $9 |
| Zolpidem | 13 | $97 | $7 |
| Methotrexate | 12 | $77 | $6 |
2016: 32 drugs
| Enbrel | 81 | $422,032 | $5,210 |
| Humira | 25 | $169,454 | $6,778 |
| Uloric | 97 | $41,182 | $425 |
| Hydroxychloroquine Sulfate | 136 | $22,605 | $166 |
| Actemra | 13 | $22,336 | $1,718 |
| Leflunomide | 67 | $18,520 | $276 |
| Methotrexate | 303 | $17,882 | $59 |
| Oxycontin | 20 | $7,567 | $378 |
| Colchicine | 28 | $6,826 | $244 |
| Prednisone | 361 | $5,864 | $16 |
| Cevimeline | 16 | $5,010 | $313 |
| Allopurinol | 113 | $2,936 | $26 |
| Colcrys | 14 | $2,793 | $199 |
| Hydrocodone-Acetaminophen | 79 | $2,225 | $28 |
| Voltaren | 24 | $1,558 | $65 |
| Celecoxib | 18 | $1,547 | $86 |
| Leucovorin | 34 | $1,431 | $42 |
| Sulfasalazine | 31 | $1,330 | $43 |
| Azathioprine | 24 | $1,255 | $52 |
| Gabapentin | 45 | $1,222 | $27 |
| Oxycodone-Acetaminophen | 22 | $1,036 | $47 |
| Tramadol | 46 | $1,031 | $22 |
| Diclofenac | 12 | $958 | $80 |
| Nabumetone | 27 | $613 | $23 |
| Methylprednisolone | 17 | $546 | $32 |
| Amitriptyline | 23 | $394 | $17 |
| Omeprazole | 18 | $388 | $22 |
| Zolpidem Tartrate Er | 14 | $304 | $22 |
| Alendronate | 30 | $208 | $7 |
| Amlodipine Besylate | 15 | $90 | $6 |
| Zolpidem | 14 | $89 | $6 |
| Cyclobenzaprine | 28 | $81 | $3 |
2015: 31 drugs
| Enbrel | 95 | $368,593 | $3,880 |
| Humira | 20 | $79,058 | $3,953 |
| Uloric | 78 | $28,657 | $367 |
| Hydroxychloroquine Sulfate | 158 | $28,436 | $180 |
| Methotrexate | 301 | $22,385 | $74 |
| Leflunomide | 64 | $11,174 | $175 |
| Oxycontin | 20 | $6,754 | $338 |
| Prednisone | 337 | $5,524 | $16 |
| Celecoxib | 20 | $4,859 | $243 |
| Colchicine | 24 | $4,658 | $194 |
| Cevimeline | 12 | $4,013 | $334 |
| Allopurinol | 107 | $2,182 | $20 |
| Hydrocodone-Acetaminophen | 78 | $1,951 | $25 |
| Sulfasalazine | 42 | $1,742 | $41 |
| Fentanyl | 12 | $1,327 | $111 |
| Leucovorin | 49 | $1,124 | $23 |
| Tramadol | 40 | $867 | $22 |
| Azathioprine | 18 | $817 | $45 |
| Oxycodone-Acetaminophen | 12 | $806 | $67 |
| Gabapentin | 48 | $791 | $16 |
| Voltaren | 13 | $770 | $59 |
| Nabumetone | 12 | $611 | $51 |
| Methylprednisolone | 23 | $598 | $26 |
| Cyclobenzaprine | 29 | $490 | $17 |
| Zolpidem | 19 | $435 | $23 |
| Amitriptyline | 22 | $372 | $17 |
| Nortriptyline | 16 | $231 | $14 |
| Omeprazole | 21 | $180 | $9 |
| Alendronate | 21 | $138 | $7 |
| Meloxicam | 22 | $123 | $6 |
| Amlodipine Besylate | 11 | $71 | $6 |
2014: 28 drugs
| Enbrel | 71 | $212,431 | $2,992 |
| Uloric | 48 | $18,590 | $387 |
| Methotrexate | 252 | $18,069 | $72 |
| Colcrys | 38 | $9,365 | $246 |
| Oxycontin | 25 | $8,048 | $322 |
| Hydroxychloroquine Sulfate | 148 | $6,214 | $42 |
| Prednisone | 394 | $5,835 | $15 |
| Cevimeline | 11 | $3,871 | $352 |
| Duloxetine | 16 | $2,787 | $174 |
| Actonel | 13 | $2,686 | $207 |
| Hydrocodone-Acetaminophen | 91 | $2,659 | $29 |
| Fentanyl | 11 | $2,613 | $238 |
| Leflunomide | 48 | $2,078 | $43 |
| Nabumetone | 14 | $1,161 | $83 |
| Allopurinol | 111 | $1,098 | $10 |
| Sulfasalazine | 30 | $1,096 | $37 |
| Oxycodone-Acetaminophen | 15 | $648 | $43 |
| Tramadol | 42 | $642 | $15 |
| Azathioprine | 13 | $557 | $43 |
| Methylprednisolone | 15 | $537 | $36 |
| Leucovorin | 36 | $490 | $14 |
| Gabapentin | 33 | $425 | $13 |
| Cyclobenzaprine | 30 | $422 | $14 |
| Omeprazole | 43 | $399 | $9 |
| Zolpidem | 34 | $264 | $8 |
| Valacyclovir | 15 | $249 | $17 |
| Alendronate | 25 | $175 | $7 |
| Amitriptyline | 21 | $173 | $8 |
2013: 27 drugs
| Enbrel | 33 | $89,059 | $2,699 |
| Orencia | 15 | $48,245 | $3,216 |
| Methotrexate | 172 | $9,740 | $57 |
| Oxycontin | 30 | $6,739 | $225 |
| Uloric | 17 | $5,884 | $346 |
| Cevimeline | 14 | $5,883 | $420 |
| Colcrys | 17 | $4,575 | $269 |
| Prednisone | 347 | $3,685 | $11 |
| Fentanyl | 12 | $3,264 | $272 |
| Hydroxychloroquine Sulfate | 104 | $2,586 | $25 |
| Leflunomide | 43 | $2,051 | $48 |
| Hydrocodone-Acetaminophen | 72 | $1,450 | $20 |
| Sulfasalazine | 22 | $828 | $38 |
| Nabumetone | 11 | $825 | $75 |
| Allopurinol | 82 | $676 | $8 |
| Omeprazole | 56 | $521 | $9 |
| Alendronate | 36 | $383 | $11 |
| Tramadol | 21 | $351 | $17 |
| Cyclobenzaprine | 23 | $241 | $10 |
| Oxycodone-Acetaminophen | 12 | $195 | $16 |
| Leucovorin | 15 | $186 | $12 |
| Zolpidem | 20 | $165 | $8 |
| Nortriptyline | 12 | $165 | $14 |
| Gabapentin | 15 | $134 | $9 |
| Simvastatin | 14 | $79 | $6 |
| Sulfamethoxazole-Trimethoprim | 11 | $57 | $5 |
| Amitriptyline | 13 | $41 | $3 |
Money from drug and device companies
$77 in 2025
| 2025 | 1 | 3 | None | $77 |
| 2024 | 2 | 3 | None | $77 |
| 2022 | 1 | 1 | None | $19 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Novartis Pharmaceuticals | Cosentyx | $77 | 3 payments
|
See all 3 published payments
| Novartis Pharmaceuticals | Meals · 2025-06-27 | Cosentyx | $22 |
| Novartis Pharmaceuticals | Meals · 2025-05-07 | Cosentyx | $28 |
| Novartis Pharmaceuticals | Meals · 2025-02-21 | Cosentyx | $28 |
See earlier years (2024, 2022)
2024: $77
| Novartis Pharmaceuticals | Cosentyx | $54 | 2 payments
|
| Genentech USA | Actemra | $23 | 1 payment
|
2022: $19
| GlaxoSmithKline | Benlysta | $19 | 1 payment
|
Professional record
- NPI
- 1659473726
- Licence
- CA A73049California A73049: Current · expires 2028-09-30
- Trained
- Stanford University School of Medicine, 1999
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2006-09-01
- NPI last updated
- 2020-05-26
- NPI record certified
- 2020-05-26
This is when the NPI record was last certified, not a medical board exam.